Organisation paid for research Program year 2022 Source: CMS Open Payments

Apex Eye

Neither a doctor nor a teaching hospital

Research payments

$682,345

8 payments

Through program year 2022, Apex Eye is reported as receiving $682,345 in research payments, across 8 payments.

By program year

4 rows
Year Kind Amount Payments
2022 Research $2,520 1
2021 Research $111,040 1
2020 Research $306,512 1
2019 Research $262,273 5

Breakdown

Who paid Research payments · program years 2019–2022
  1. Novartis Pharmaceuticals Corporation $675,157 4 payments
  2. Perrigo Company plc $5,000 1 payment
  3. Osmotica Pharmaceutical Corp. $2,038 2 payments
  4. Allergan Inc. $150 1 payment
Studies the money was for Research payments · program years 2019–2022
  1. A Multicenter Randomized Double Masked Phase 3A Study to Assess Safety and Efficacy of Brolucizumab 6 MG Q4 Weeks Compared to Aflibercept 2 MG Q4 Weeks in Patients With Neovascular Age Related MacUlar Degeneration Namd With Persistent Retinal Fluid $675,157 4 payments
  2. Bioequivalence study between Perrigo's product and Azopt ophthalmic Suspension $5,000 1 payment
  3. Rvl-202 $2,038 2 payments
  4. A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-Related MacUlar Degeneration $150 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record